Feb 18, 2016
Dr. Marc Lemonnier, co-founder and CEO of Antabio, will participate in a BioPharma Dealmakers webcast, sponsored in part by Antabio, featuring five companies innovating antibiotic technologies. The webcast, part of the BioPharma Dealmakers series, is scheduled for 8AM...
Jan 21, 2016
On January 21 2016. The Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at an event at the World Economic Forum in Davos, Switzerland. This was drafted, agreed and signed by ANTABIO among...
May 12, 2015
Antabio SAS, a leading biopharmaceutical company in the field of antibacterial drug discovery, announced today that it has received a Wellcome Trust Seeding Drug Discovery Award to develop novel small molecule drugs for the treatment of chronic Pseudomonas infections...
Apr 30, 2015
Antabio is now a member of the newly launched Alliance of Biotechs of Europe innovating in Anti-Microbial Resistance, called the BEAM Alliance. This group of European biotechnology companies is committed to tackling the unique challenges facing the industry in the...
Apr 9, 2015
Antabio SAS, a French antibacterial drug discovery company, and Bpifrance, announce that Antabio will receive EUR 1 million in funding to support its Antibiotic Adjuvant Factory (“The Factory”) dedicated to the discovery and development of new antibacterial...
